Notice Number: NOT-RM-17-001

Key Dates
Release Date: November 16, 2016

Issued by
Office of Strategic Coordination (Common Fund)

Purpose

The National Cancer Institute (NCI), on behalf of the Common Fund, will host an informational/technical assistance pre-application webinar for investigators who are planning to submit an application in response to RFA-RM-16-024 Knowledge Management Center for Illuminating the Druggable Genome (U24) , RFA-RM-16-025 Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24) , or RFA-RM-16-026 Data and Resource Generation Centers for Illuminating the Druggable Genome (U24) .

The intent of the webinar is to provide prospective applicants with information on the IDG Program and to address questions pertinent to preparing applications. The webinar is optional and not required for application submission. No pre-registration is required, but questions will be taken in advance and can be sent to the appropriate contact below. For more information on the Illuminating the Druggable Genome Program, please visit the program website https://commonfund.nih.gov/idg/index

Webinar Information
Date: Tuesday, December 13, 2016
Time: 3:30 P.M. to 5:00 P.M., EST
Meeting URL: Join WebEx meeting
Meeting Password: 4mJu3GJ@
Call-in number: 1-855-244-8681 (toll-free US/Canada), 1-650-479-3207 (US/Canada)
Meeting number (access code): 735 137 640text here

Inquiries

For questions about RFA-RM-16-024 "Knowledge Management Center for Illuminating the Druggable Genome", please contact:

Jean C. ZenKlusen, Lic.Chem., Ph.D.
National Cancer Institute (NCI)
Email: [email protected]

For questions about RFA-RM-16-025 Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24) , please contact:

Christine M. Colvis, Ph.D.
NCATS
Email: [email protected]

For questions about RFA-RM-16-026 Data and Resource Generation Centers for Illuminating the Druggable Genome (U24) , please contact:

Aaron Pawlyk, Ph.D.
NIDDK
Email: [email protected]

For general questions about the Illuminating the Druggable Genome Program, please contact:

Jenna Baker, Ph.D.
NIDDK
Email: [email protected]